CPT Code 11721: The Complete Nail Debridement Billing Guide for 2026

What Is CPT Code 11721?

CPT code 11721 is the procedure code used to report the debridement of six or more nails by any method in a single encounter. Medicare classifies it as routine foot care and covers it only when the patient has a qualifying systemic condition documented with a Q7, Q8, or Q9 class finding modifier on the claim.

11721 vs 11720:
CPT 11720 covers 1 to 5 nails at approximately $30.10 under Medicare. CPT 11721 covers 6 or more nails at $45.09. The two cannot be billed together on the same date of service.

2026 Medicare reimbursement:
The national office rate is $45.09, from a total RVU of 1.35 multiplied by the 2026 conversion factor of $33.4009. The facility rate is $21.39.

Frequency and denial risk:
Medicare limits nail debridement to once every 60 days, six sessions per rolling 12-month period. Missing the Q modifier, omitting the systemic diagnosis, or billing inside the window are the top three denial triggers.

What Does CPT Code 11721 Cover?

CPT code 11721 is defined by the American Medical Association as “debridement of nail(s) by any method(s); 6 or more.” It reports the removal of dystrophic, mycotic, thickened, or otherwise abnormal nail material from six or more nails during a single visit. The method does not change the code: manual filing and trimming, motorized rotary burr reduction, chemical softening agents, or any combination all fall under 11721 as long as six or more nails are treated. The code applies regardless of which toes are involved, and the debridement can span both feet in a single session.

This code is one of the highest-volume procedure codes in podiatry, performed nearly 1.9 million times per year. It sits in the integumentary surgery section of the CPT manual under nail procedures, alongside 11720 (1 to 5 nails), 11719 (trimming, any number), and 11730 (nail avulsion). Despite that volume, 11721 is one of the most denial-prone codes in podiatric billing because Medicare classifies nail debridement as routine foot care, which is statutorily excluded unless specific clinical conditions and documentation requirements are met.

One question we hear constantly from podiatry practices is why their nail debridement claims keep getting denied even though the patient has a qualifying condition. In our experience matching providers with billing partners, the answer traces back to one of three gaps: the Q modifier was missing, the class finding was undocumented, or the claim hit the 60-day frequency window.

CPT 11721 vs CPT 11720: Which Code Applies?

The distinction between these two codes turns entirely on nail count. CPT 11720 covers debridement of 1 to 5 nails. CPT 11721 covers 6 or more. Both are billed as one unit per date of service regardless of the exact count above or below that threshold. Per CMS Billing and Coding Article A57193, a practice cannot bill multiple units of either code on the same date, and the two codes cannot appear together on the same claim for the same encounter.

Upcoding from 11720 to 11721 when fewer than six nails were debrided is a compliance risk auditors specifically target. The chart note must document each individual nail, including which foot and which toes, so the count is verifiable on audit review. Downcoding is less common but still costly: billing 11720 when eight nails were actually treated leaves roughly $15 per visit on the table, which compounds quickly across a full patient panel.

Factor	CPT 11720	CPT 11721
Nail count	1 to 5	6 or more
2026 office rate	~$30.10	$45.09
Frequency	Every 60 days	Every 60 days
Q modifier	Yes (Q7/Q8/Q9)	Yes (Q7/Q8/Q9)

For a full breakdown of nail and surgical codes, see our podiatry billing and coding cheat sheet.

Medicare Coverage and Qualifying Conditions

Medicare does not cover routine foot care by default. Nail debridement under CPT 11721 becomes covered only when the patient has a documented systemic condition that places the feet at risk and the provider appends the correct class finding modifier. Without both elements on the claim, the service is denied as routine foot care, a statutory exclusion rather than a medical necessity determination. This distinction matters because a statutory denial cannot be appealed on clinical grounds.

Qualifying systemic conditions recognized by CMS include diabetes mellitus, peripheral vascular disease, peripheral neuropathy, Buerger disease, and arteriosclerosis obliterans, among others in the applicable Local Coverage Determination. For mycotic nail debridement specifically, CMS requires ICD-10 code B35.1 (tinea unguium) as the primary or co-primary diagnosis, with a secondary diagnosis confirming pain in the toes, marked limitation in ambulation, or secondary infection, per CMS Article A56640.

Providers often come to us after months of watching nail debridement denials pile up with no clear pattern. When we help them look at the claims data, the issue is almost always modifier-related: the systemic condition is in the chart but the Q modifier was never appended, or the class finding does not match the modifier on the claim. A podiatry billing partner catches these process errors before the claim ships. For the ICD-10 codes involved, see our guides on B35.1 for tinea unguium and I73.9 for peripheral vascular disease.

How Do Q7, Q8, and Q9 Modifiers Work for CPT 11721?

Medicare requires one of three class finding modifiers appended to CPT 11721 on every claim. These modifiers tell the payer which category of systemic risk the patient meets. Claims without the correct Q modifier are denied as non-covered routine foot care regardless of whether the qualifying condition exists in the chart. The modifier is the proof that the condition was evaluated at the point of care, not just present in the problem list.

Q7 indicates one Class A finding, such as non-traumatic amputation of the foot. Q8 indicates two Class B findings, which include absent or diminished pedal pulses and advanced trophic changes (hair growth decrease, nail thickening, skin discoloration, thin fragile skin). Q9 indicates one Class B finding plus two Class C findings. Class C findings include claudication, temperature changes, edema, paresthesias, and loss of protective sensation.

Every finding must come from the same foot that was treated. Mixing findings from the left foot and right foot to meet a modifier threshold is a common compliance error and a frequent cause of post-payment audit takebacks. When a patient qualifies under multiple classes, use the modifier that best matches the primary risk in the encounter note.

When the patient lacks a qualifying condition, the provider must choose the correct coverage modifier. A signed Advance Beneficiary Notice (ABN) with modifier GA shifts financial responsibility to the patient. Without an ABN, modifier GZ applies. For statutorily non-covered services, use modifier GY.

CPT 11721 Reimbursement and Cost in 2026

Medicare reimburses CPT 11721 using the Resource-Based Relative Value Scale. For 2026, the work RVU is 0.53. In a non-facility (office) setting, the total RVU is 1.35, yielding a national base allowance of $45.09 at the 2026 conversion factor of $33.4009. In a facility setting, the total RVU drops to 0.64, producing a payment of $21.39.

These are national figures before geographic adjustment. Each MAC applies GPCIs that shift payment by locality, and the 2% sequestration reduction applies after that. Commercial payers typically reimburse at 120% to 150% of Medicare. Without insurance, the average charge is approximately $82.92, though cash-pay rates often fall between $40 and $75. For strategies on improving collections, see our guide on maximizing revenue in your podiatry practice.

Component	Value
Work RVU	0.53
Total Non-Facility RVU	1.35
Total Facility RVU	0.64
2026 Conversion Factor	$33.4009
Office Rate	$45.09
Facility Rate	$21.39
Avg Charge	~$82.92
Frequency	Every 60 days (6/year)

How to Bill CPT 11721 Correctly

Clean billing for CPT 11721 follows a consistent sequence. These six steps separate first-pass clean claims from denial-and-rework cycles.

1. Document each nail individually. Record which foot and which toes were debrided. Include each nail’s thickness, color, dystrophy, and the clinical reason debridement was necessary. CMS requires documentation for at least six nails.
2. Confirm the qualifying systemic condition. Verify the patient has a documented systemic diagnosis in their active problem list. For mycotic nails, list B35.1 as primary and the systemic condition as secondary.
3. Document the class finding in the encounter note. Record the specific Class A, B, or C findings on examination, tied to the treated foot. The finding must match the Q modifier you will append.
4. Append the correct Q modifier. Add Q7, Q8, or Q9 to CPT 11721. If the patient lacks a qualifying condition and you have a signed ABN, append GA instead. Without an ABN, append GZ.
5. Check the frequency window. Verify the patient has not had nail debridement billed within the past 60 days. Billing inside the window triggers an automatic frequency denial.
6. Pair with the correct diagnosis codes. Primary: the nail condition (B35.1 for onychomycosis, L60.3 for dystrophy). Secondary: the systemic condition (E11.42 for type 2 diabetes with polyneuropathy, I73.9 for peripheral vascular disease).

Common CPT 11721 Denials and How to Fix Them

The biggest issue we see podiatry practices run into with CPT 11721 is treating denials as random rather than systematic. The same five denial reasons account for the vast majority of rejected nail debridement claims, and every one is fixable at the process level.

• Missing Q modifier. The claim goes out without Q7, Q8, or Q9 appended. The fix: build a claim scrub rule that blocks submission of 11721 without a Q modifier.
• Missing systemic diagnosis. The nail condition is listed but the qualifying systemic diagnosis is absent. The fix: require a secondary systemic ICD-10 code on every 11721 claim as a mandatory field.
• Frequency violation. The claim is submitted fewer than 60 days after the last nail debridement service. The fix: track each patient’s last 11720/11721 service date and flag encounters booked inside the window before the claim is created.
• Insufficient documentation. The chart note does not describe six individual nails with condition and clinical necessity. The fix: use a structured encounter template that prompts per-nail documentation by location, condition, and thickness.
• Class finding mismatch. The modifier does not match the documented findings. The fix: add a pre-submission check comparing the modifier to the chart findings before release. For how nail avulsion coding differs from debridement, see our guide on CPT code 11730.

What Documentation Does CPT 11721 Require?

CMS and most MACs require a specific documentation standard for CPT 11721 to survive post-payment audit. The chart note must include the qualifying systemic condition in the active problem list with the ICD-10 code, the Class A, B, or C findings stated explicitly and tied to the treated foot, and a per-nail description of the debridement performed.

Each nail description should include the specific toe, the foot (left or right), the nail’s appearance (thickness, color, dystrophic changes), and the symptomatology that made debridement necessary. The note must also record the debridement method and confirm six or more nails were treated. For mycotic nails, document onychomycosis and the secondary condition (pain, ambulation limitation, or secondary infection) that establishes coverage.

In our experience matching practices with billing companies, providers who use a structured nail debridement encounter template produce far fewer audit takebacks than those who free-text their notes. The template forces every required element onto the page: systemic condition, class finding tied to the correct foot, and a per-nail grid. Practices billing CPT 11721 at volume without a template rely on provider memory for compliance, which is the most common root cause of documentation denials.

Frequently Asked Questions

Next Steps

• New to podiatry coding? Start with our podiatry billing and coding cheat sheet for the full CPT and modifier reference.
• Dealing with fungal nail diagnoses? See our guide on ICD-10 code B35.1 for tinea unguium to pair the right diagnosis with your 11721 claims.
• Need the nail avulsion code instead? Read our breakdown of CPT code 11730 for avulsion billing and documentation.
• Ready to hand billing off? Get matched with vetted podiatry billing companies that know foot care coding and catch the denials others miss.